You are here

Home

Clinical Trials: Neuromuscular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, May 8, 2019 - 12:00
In Vivo Analysis of Muscle Stem Cells in Chronic and Acute Lower Limb Ischemia (MyostemIschemia)
Conditions:   Artery Disease;   Muscle Disorder
Intervention:   Procedure: Gastrocnemius muscle biopsy
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting
Posted: Friday, October 26, 2018 - 12:00
Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome
Condition:   Carpal Tunnel Syndrome
Interventions:   Other: Fat Injection;   Drug: Steroid Injection
Sponsors:   Columbia University;   Orthopaedic Scientific Research Foundation
Recruiting
Posted: Thursday, August 16, 2018 - 12:00
Comparative Study of Strategies for Management of Duchenne Myopathy (DM)
Condition:   Myopathy
Interventions:   Drug: Sildenafil (Phosphodiesterase inhibitors);   Drug: Prednisolone (Steroids);   Procedure: Mesenchymal stem cell transplantation
Sponsor:   Assiut University
Not yet recruiting
Posted: Thursday, March 29, 2018 - 12:00
A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition:   ALS (Amyotrophic Lateral Sclerosis)
Intervention:   Biological: AstroRx
Sponsor:   Kadimastem
Not yet recruiting
Posted: Tuesday, January 23, 2018 - 12:00
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Conditions:   Muscular Dystrophies;   Muscular Dystrophy, Duchenne;   Muscular Disorders, Atrophic;   Muscular Diseases;   Neuromuscular Diseases;   Nervous System Diseases;   Genetic Diseases, X-Linked;   Genetic Diseases, Inborn
Interventions:   Biological: CAP-1002;   Drug: Placebo
Sponsor:   Capricor Inc.
Not yet recruiting
Posted: Wednesday, August 30, 2017 - 12:00
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
Conditions:   ALS;   Amyotrophic Lateral Sclerosis
Intervention:   Drug: Autologous Adipose-derived Mesenchymal Stromal Cells
Sponsors:   Mayo Clinic;   State of Minnesota Regenerative Medicine Minnesota
Not yet recruiting - verified August 2017
Posted: Sunday, July 9, 2017 - 12:00
Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: HYNRCS-Allo inj
Sponsors:   Hanyang University Seoul Hospital;   Corestem, Inc.
Recruiting - verified July 2017
Posted: Wednesday, May 24, 2017 - 12:00
Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy
Condition:   Non Arteritic Ischemic Optic Neuropathy
Intervention:   Procedure: intravitreal injection of MSV
Sponsors:   Instituto Universitario de Oftalmobiología Aplicada;   University of Valladolid
Not yet recruiting - verified June 2017
Posted: Wednesday, March 1, 2017 - 12:00
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
Condition:   Duchenne Muscular Dystrophy
Intervention:   Biological: Stem Cells
Sponsor:   Stem Cells Arabia
Recruiting
Posted: Sunday, January 1, 2017 - 12:00
Stem Cell Ophthalmology Treatment Study II
Conditions:   Retinal Disease;   Age-Related Macular Degeneration;   Retinitis Pigmentosa;   Stargardt Disease;   Optic Neuropathy;   Nonarteritic Ischemic Optic Neuropathy;   Optic Atrophy;   Optic Nerve Disease;   Glaucoma;   Leber Hereditary Optic Neuropathy
Interventions:   Procedure: Arm 1;   Procedure: Arm 2;   Procedure: Arm 3
Sponsor:   MD Stem Cells
Recruiting - verified January 2017

Pages